SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
US Stock MarketDetailed Quotes
SNTI Senti Biosciences
- 4.1400
- -0.0300-0.72%
Close Dec 26 16:00 ET
19.00MMarket Cap-0.27P/E (TTM)
4.1600High4.0100Low55.02KVolume4.1500Open4.1700Pre Close225.10KTurnover1.89%Turnover RatioLossP/E (Static)4.59MShares16.940052wk High1.19P/B12.08MFloat Cap1.520152wk Low--Dividend TTM2.92MShs Float105.4000Historical High--Div YieldTTM3.60%Amplitude1.5200Historical Low4.0900Avg Price1Lot Size
Senti Biosciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | -39.81%1.98M | 0 | -83.18%255K | -38.00%687K | 21.31%1.04M | 43.43%3.29M | -135.17%-191K |
| Operating revenue | --0 | --0 | --0 | -39.81%1.98M | --0 | -83.18%255K | -38.00%687K | 21.31%1.04M | 43.43%3.29M | -135.17%-191K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -19.19%14.9M | -15.87%13.36M | 1.88%16.3M | 5.16%68.74M | 10.99%18.43M | 13.38%18.44M | -30.61%15.88M | 26.86%16M | 52.96%65.37M | 45.28%16.6M |
| Selling and administrative expenses | -34.42%5.53M | -60.55%3.49M | -24.54%6.8M | -7.35%34.87M | -6.99%8.58M | -15.59%8.44M | -36.30%8.84M | 71.31%9.01M | 77.10%37.63M | 75.06%9.22M |
| -General and administrative expense | -34.42%5.53M | -60.55%3.49M | -24.54%6.8M | -7.35%34.87M | -6.99%8.58M | -15.59%8.44M | -36.30%8.84M | 71.31%9.01M | 77.10%37.63M | 75.06%9.22M |
| Research and development costs | -4.81%8.66M | 33.09%9.15M | 24.37%8.78M | 14.23%32.15M | 29.63%9.12M | 39.47%9.09M | -25.64%6.88M | -7.16%7.06M | 28.18%28.15M | 9.80%7.04M |
| Depreciation amortization depletion | -28.17%714K | 76.35%716K | 297.80%724K | 289.86%2.31M | --726K | --994K | --406K | --182K | --592K | ---- |
| -Depreciation and amortization | -28.17%714K | 76.35%716K | 297.80%724K | 289.86%2.31M | --726K | --994K | --406K | --182K | --592K | ---- |
| Other operating expenses | ---- | ---- | ---- | 41.70%-583K | --0 | 66.80%-83K | 0.00%-250K | 0.00%-250K | -112.77%-1M | 0.00%-250K |
| Operating profit | 18.05%-14.9M | 12.06%-13.36M | -8.93%-16.3M | -7.54%-66.77M | -9.72%-18.43M | -23.30%-18.19M | 30.24%-15.19M | -27.27%-14.96M | -53.50%-62.08M | -54.29%-16.79M |
| Net non-operating interest income expense | -74.27%150K | -70.28%236K | -68.80%331K | 68.37%2.86M | -62.23%426K | 7.56%583K | 2,840.74%794K | 26,425.00%1.06M | 15,363.64%1.7M | 28,100.00%1.13M |
| Non-operating interest income | -74.27%150K | -70.28%236K | -68.80%331K | 68.37%2.86M | -62.23%426K | 7.56%583K | 2,840.74%794K | 26,425.00%1.06M | 15,363.64%1.7M | 28,100.00%1.13M |
| Other net income (expense) | 25.77%-14.11M | 1,231.25%1.92M | 7,466.67%3.86M | -281.98%-19.51M | -201.33%-687K | -19,501.03%-19.01M | -98.59%144K | 194.44%51K | 172.01%10.72M | 3,047.83%678K |
| Gain on sale of security | -366.65%-15.45M | --324K | --2.4M | --3.96M | ---1.83M | --5.79M | ---- | ---- | ---- | ---- |
| Special income (charges) | 98.78%-313K | --0 | --0 | -339.58%-25.76M | -139.74%-271K | -25,850.51%-25.69M | -98.54%148K | --59K | 48,963.64%10.75M | 5,346.15%682K |
| -Less：Restructuring and merger&acquisition | --0 | --0 | --0 | 97.81%-207K | --0 | --0 | 98.33%-148K | ---59K | ---9.46M | ---682K |
| -Less:Impairment of capital assets | -98.78%313K | ---- | ---- | --25.96M | --271K | --25.69M | ---- | ---- | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.29M | --0 |
| Other non- operating income (expenses) | 85.99%1.65M | 39,925.00%1.59M | 18,362.50%1.46M | 7,256.25%2.29M | 35,525.00%1.42M | 44,150.00%885K | -116.00%-4K | 85.19%-8K | 99.78%-32K | 60.00%-4K |
| Income before tax | 21.16%-28.87M | 21.38%-11.2M | 12.57%-12.11M | -67.94%-83.41M | -24.69%-18.69M | -156.00%-36.62M | -23.36%-14.25M | -17.31%-13.85M | 10.22%-49.67M | -37.45%-14.99M |
| Income tax | ||||||||||
| Net income | -93.43%-28.87M | 40.08%-11.2M | 35.31%-12.11M | -22.07%-71.06M | -2.78%-18.72M | 10.32%-14.92M | -61.85%-18.7M | -58.55%-18.72M | -5.23%-58.21M | -67.00%-18.21M |
| Net income continuous Operations | 21.16%-28.87M | 21.38%-11.2M | 12.57%-12.11M | -67.94%-83.41M | -24.69%-18.69M | -156.00%-36.62M | -23.36%-14.25M | -17.31%-13.85M | 10.22%-49.67M | -37.45%-14.99M |
| Net income discontinuous operations | --0 | --0 | --0 | 244.51%12.35M | 99.13%-28K | 1,028.20%21.69M | ---4.45M | ---4.87M | ---8.55M | ---3.22M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -93.43%-28.87M | 40.08%-11.2M | 35.31%-12.11M | -22.07%-71.06M | -2.78%-18.72M | 10.32%-14.92M | -61.85%-18.7M | -58.55%-18.72M | -5.23%-58.21M | -67.00%-18.21M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -93.43%-28.87M | 40.08%-11.2M | 35.31%-12.11M | -22.07%-71.06M | -2.78%-18.72M | 10.32%-14.92M | -61.85%-18.7M | -58.55%-18.72M | -5.23%-58.21M | -67.00%-18.21M |
| Basic earnings per share | -87.80%-6.31 | 41.94%-2.45 | 38.10%-2.6 | 28.25%-16 | 0.48%-4.18 | 11.58%-3.36 | 50.93%-4.22 | -55.28%-4.2 | -75.99%-22.3 | -68.16%-4.2 |
| Diluted earnings per share | -87.80%-6.31 | 41.94%-2.45 | 38.10%-2.6 | 28.25%-16 | 0.48%-4.18 | 11.58%-3.36 | 50.93%-4.22 | -55.28%-4.2 | -75.99%-22.3 | -68.16%-4.2 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |